SCHEMBL324878

SCHEMBL324878

Cc1ccsc1C(=O)N1CCOCC1

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
GLA P06280 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
HPGD P15428 3/20 0.51
RAB9A P51151 1/20 0.49
CNR1 P21554 1/20 0.49
SIGLEC9 Q9Y336 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9792238 0.81 HPGD (0.55) ALDH1A1GLASMN1; SMN2HPGDRAB9A
SCHEMBL5257314 0.81 CA12 (0.57) ALDH1A1GLASMN1; SMN2CA12CA1
SCHEMBL7094585 0.79 SIGLEC9 (0.56) ALDH1A1CA12CA1CA2CA7
SCHEMBL7094543 0.78 SIGLEC9 (0.55) ALDH1A1CA12CA1CA2CA7
SCHEMBL3764385 0.78 CA12 (0.60) ALDH1A1GLASMN1; SMN2CA12CA1
SCHEMBL4164258 0.77 HPGD (0.57) ALDH1A1GLASMN1; SMN2HPGD
SCHEMBL2013741 0.77 ALDH1A1 (0.52) ALDH1A1GLASMN1; SMN2CA12CA1
SCHEMBL3764389 0.77 CA12 (0.59) ALDH1A1GLASMN1; SMN2CA12CA1
SCHEMBL8126721 0.76 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2HPGD
SCHEMBL26981190 0.75 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3685231-B1 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) 2026-05-13 EP claimed
CN-116940647-A Curable adhesive composition comprising maleimide and thiol 汉高股份有限及两合公司 2023-10-24 CN claimed
US-11479620-B2 3D printing with polymeric nanogel particles THE REGENTS OF THE UNIVERSITY OF COLORADO (US) 2022-10-25 US claimed
US-20200283548-A1 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2020-09-10 US claimed
US-10756309-B2 Light-emitting display device SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-25 US claimed
US-20190280250-A1 LIGHT-EMITTING DISPLAY DEVICE SAMSUNG DISPLAY CO LTD (KR) 2019-09-12 US claimed
US-10312443-B2 Method of manufacturing light-emitting display device and light-emitting display device manufactured using the method SAMSUNG DISPLAY CO., LTD. (KR) 2019-06-04 US claimed
US-20160343940-A1 METHOD OF MANUFACTURING LIGHT-EMITTING DISPLAY DEVICE AND LIGHT-EMITTING DISPLAY DEVICE MANUFACTURED USING THE METHOD SAMSUNG DISPLAY CO., LTD. (KR) 2016-11-24 US claimed
EP-3685231-B1 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) 2026-05-13 EP disclosed
US-20260008918-A1 CROSSLINKABLE POLYMER COMPOSITION, CROSSLINKED PRODUCT, AND CROSSLINKED FOAM ZEON CORPORATION (JP) 2026-01-08 US disclosed
EP-4563652-A1 CROSSLINKABLE POLYMER COMPOSITION, CROSSLINKED PRODUCT, AND CROSSLINKED FOAM Zeon Corporation (JP) 2025-06-04 EP disclosed
US-20240425631-A1 LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2024-12-26 US disclosed
EP-3475323-B1 CONTROL OF POLYMER NETWORK STRUCTURES VIA NANOGELS UNIV COLORADO REGENTS (US) 2024-12-11 EP disclosed
CN-116940647-A Curable adhesive composition comprising maleimide and thiol 汉高股份有限及两合公司 2023-10-24 CN disclosed
EP-2202250-A2 Water-swellable copolymers and articles and coating made therefrom Tyco Healthcare Group LP (US) 2010-06-30 EP disclosed
EP-2143740-A2 Water-swellable copolymers and articles and coating made therefrom TYCO HEALTHCARE GROUP LP (US) 2010-01-13 EP disclosed
EP-2131883-A2 ENDOTRACHEAL CUFF AND TECHNIQUE FOR USING THE SAME NELLCOR PURITAN BENNETT LLC (US) 2009-12-16 EP disclosed
WO-2008109009-A2 ENDOTRACHEAL CUFF AND TECHNIQUE FOR USING THE SAME NELLCOR PURITAN BENNETT LLC (US) 2008-09-12 WO disclosed
US-20080215034-A1 Endotracheal cuff and technique for using the same NELLCOR PURITAN BENNETT LLC 2008-09-04 US disclosed
US-20080064839-A1 Formed from 3-sulfopropyl acrylate potassium salt, sodium acrylate, N-(tris(hydroxyl methyl)methyl)acrylamide, and 2-acrylamideo-2-methyl-1-propane sulfonic acid as monomers; sutures; surgical staples COVIDIEN LP 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008918-A1 CROSSLINKABLE POLYMER COMPOSITION, CROSSLINKED PRODUCT, AND CROSSLINKED FOAM RAD51, RAD1, FGB ALDH1A1 772/4885GLA 3172/4885SMN1; SMN2 1223/4885
US-20240425631-A1 LOW VISCOSITY URETHANE (METH)ACRYLATE MONOMERS AND THEIR USE IN PRODUCTION OF TOUGH POLYMERS WITH WELL-CONTROLLED MODULUS AND STRENGTH PUF60, ACR, UMPS ALDH1A1 1480/4885GLA 1939/4885SMN1; SMN2 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.